South African amaXhosa patients with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin

FLG mutations lead to reduced levels of filaggrin degradation products in the SC in a dose-dependent fashion.5 It has been shown that moderate-to-severe AD also has an effect on SC filaggrin expression6 as well as on the levels of filaggrin degradation products5 possibly due to the systemic TH2 immu...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Journal of allergy and clinical immunology Ročník 133; číslo 1; s. 280 - 282.e2
Hlavní autori: Thawer-Esmail, Fatemah, Jakasa, Ivone, Todd, Gail, Wen, Yaran, Brown, Sara J., Kroboth, Karin, Campbell, Linda E., O'Regan, Grainne M., McLean, W.H. Irwin, Irvine, Alan D., Kezic, Sanja, Sandilands, Aileen
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: New York, NY Elsevier Inc 01.01.2014
Elsevier
Elsevier Limited
Mosby
Predmet:
ISSN:0091-6749, 1097-6825, 1097-6825
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:FLG mutations lead to reduced levels of filaggrin degradation products in the SC in a dose-dependent fashion.5 It has been shown that moderate-to-severe AD also has an effect on SC filaggrin expression6 as well as on the levels of filaggrin degradation products5 possibly due to the systemic TH2 immune response.6 In the present study, the levels of both PCA and UCA and their sum were significantly decreased in the SC of patients with AD than in control subjects (Fig 1; see Table E1 in this article's Online Repository at www.jacionline.org). [...]FLG LOF mutations are not a significant contributor to AD in the amaXhosa population.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Correspondence-1
content type line 23
ISSN:0091-6749
1097-6825
1097-6825
DOI:10.1016/j.jaci.2013.09.053